Chapter/Section Purchase

1 Study Coverage
1.1 Herpes Zoste Drug Product Introduction
1.2 Market by Type
1.2.1 Global Herpes Zoste Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Acyclovir
1.2.3 Amenamevir
1.2.4 FV-100
1.2.5 GLS-5100
1.2.6 GSK-1437173A
1.2.7 NAL-3221
1.2.8 Others
1.3 Market by Application
1.3.1 Global Herpes Zoste Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Herpes Zoste Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Herpes Zoste Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Herpes Zoste Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Herpes Zoste Drug Sales by Region
2.4.1 Global Herpes Zoste Drug Sales by Region (2017-2022)
2.4.2 Global Sales Herpes Zoste Drug by Region (2023-2028)
2.5 Global Herpes Zoste Drug Revenue by Region
2.5.1 Global Herpes Zoste Drug Revenue by Region (2017-2022)
2.5.2 Global Herpes Zoste Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Herpes Zoste Drug Sales by Manufacturers
3.1.1 Global Top Herpes Zoste Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Herpes Zoste Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herpes Zoste Drug in 2021
3.2 Global Herpes Zoste Drug Revenue by Manufacturers
3.2.1 Global Herpes Zoste Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Herpes Zoste Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Herpes Zoste Drug Revenue in 2021
3.3 Global Herpes Zoste Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Herpes Zoste Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Herpes Zoste Drug Sales by Type
4.1.1 Global Herpes Zoste Drug Historical Sales by Type (2017-2022)
4.1.2 Global Herpes Zoste Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Herpes Zoste Drug Sales Market Share by Type (2017-2028)
4.2 Global Herpes Zoste Drug Revenue by Type
4.2.1 Global Herpes Zoste Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Herpes Zoste Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Herpes Zoste Drug Revenue Market Share by Type (2017-2028)
4.3 Global Herpes Zoste Drug Price by Type
4.3.1 Global Herpes Zoste Drug Price by Type (2017-2022)
4.3.2 Global Herpes Zoste Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Herpes Zoste Drug Sales by Application
5.1.1 Global Herpes Zoste Drug Historical Sales by Application (2017-2022)
5.1.2 Global Herpes Zoste Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Herpes Zoste Drug Sales Market Share by Application (2017-2028)
5.2 Global Herpes Zoste Drug Revenue by Application
5.2.1 Global Herpes Zoste Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Herpes Zoste Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Herpes Zoste Drug Revenue Market Share by Application (2017-2028)
5.3 Global Herpes Zoste Drug Price by Application
5.3.1 Global Herpes Zoste Drug Price by Application (2017-2022)
5.3.2 Global Herpes Zoste Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Herpes Zoste Drug Market Size by Type
6.1.1 North America Herpes Zoste Drug Sales by Type (2017-2028)
6.1.2 North America Herpes Zoste Drug Revenue by Type (2017-2028)
6.2 North America Herpes Zoste Drug Market Size by Application
6.2.1 North America Herpes Zoste Drug Sales by Application (2017-2028)
6.2.2 North America Herpes Zoste Drug Revenue by Application (2017-2028)
6.3 North America Herpes Zoste Drug Market Size by Country
6.3.1 North America Herpes Zoste Drug Sales by Country (2017-2028)
6.3.2 North America Herpes Zoste Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Herpes Zoste Drug Market Size by Type
7.1.1 Europe Herpes Zoste Drug Sales by Type (2017-2028)
7.1.2 Europe Herpes Zoste Drug Revenue by Type (2017-2028)
7.2 Europe Herpes Zoste Drug Market Size by Application
7.2.1 Europe Herpes Zoste Drug Sales by Application (2017-2028)
7.2.2 Europe Herpes Zoste Drug Revenue by Application (2017-2028)
7.3 Europe Herpes Zoste Drug Market Size by Country
7.3.1 Europe Herpes Zoste Drug Sales by Country (2017-2028)
7.3.2 Europe Herpes Zoste Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Herpes Zoste Drug Market Size by Type
8.1.1 Asia Pacific Herpes Zoste Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Herpes Zoste Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Herpes Zoste Drug Market Size by Application
8.2.1 Asia Pacific Herpes Zoste Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Herpes Zoste Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Herpes Zoste Drug Market Size by Region
8.3.1 Asia Pacific Herpes Zoste Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Herpes Zoste Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Herpes Zoste Drug Market Size by Type
9.1.1 Latin America Herpes Zoste Drug Sales by Type (2017-2028)
9.1.2 Latin America Herpes Zoste Drug Revenue by Type (2017-2028)
9.2 Latin America Herpes Zoste Drug Market Size by Application
9.2.1 Latin America Herpes Zoste Drug Sales by Application (2017-2028)
9.2.2 Latin America Herpes Zoste Drug Revenue by Application (2017-2028)
9.3 Latin America Herpes Zoste Drug Market Size by Country
9.3.1 Latin America Herpes Zoste Drug Sales by Country (2017-2028)
9.3.2 Latin America Herpes Zoste Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Herpes Zoste Drug Market Size by Type
10.1.1 Middle East and Africa Herpes Zoste Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Herpes Zoste Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Herpes Zoste Drug Market Size by Application
10.2.1 Middle East and Africa Herpes Zoste Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Herpes Zoste Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Herpes Zoste Drug Market Size by Country
10.3.1 Middle East and Africa Herpes Zoste Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Herpes Zoste Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Overview
11.1.3 Astellas Pharma Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Astellas Pharma Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Astellas Pharma Inc. Recent Developments
11.2 Beijing Minhai Biotechnology Co., Ltd
11.2.1 Beijing Minhai Biotechnology Co., Ltd Corporation Information
11.2.2 Beijing Minhai Biotechnology Co., Ltd Overview
11.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
11.3 ContraVir Pharmaceuticals, Inc.
11.3.1 ContraVir Pharmaceuticals, Inc. Corporation Information
11.3.2 ContraVir Pharmaceuticals, Inc. Overview
11.3.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ContraVir Pharmaceuticals, Inc. Recent Developments
11.4 Epiphany Biosciences, Inc.
11.4.1 Epiphany Biosciences, Inc. Corporation Information
11.4.2 Epiphany Biosciences, Inc. Overview
11.4.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Epiphany Biosciences, Inc. Recent Developments
11.5 Foamix Pharmaceuticals Ltd.
11.5.1 Foamix Pharmaceuticals Ltd. Corporation Information
11.5.2 Foamix Pharmaceuticals Ltd. Overview
11.5.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Foamix Pharmaceuticals Ltd. Recent Developments
11.6 GeneOne Life Science, Inc.
11.6.1 GeneOne Life Science, Inc. Corporation Information
11.6.2 GeneOne Life Science, Inc. Overview
11.6.3 GeneOne Life Science, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GeneOne Life Science, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GeneOne Life Science, Inc. Recent Developments
11.7 GlaxoSmithKline Plc
11.7.1 GlaxoSmithKline Plc Corporation Information
11.7.2 GlaxoSmithKline Plc Overview
11.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline Plc Recent Developments
11.8 Merck & Co., Inc.
11.8.1 Merck & Co., Inc. Corporation Information
11.8.2 Merck & Co., Inc. Overview
11.8.3 Merck & Co., Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck & Co., Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck & Co., Inc. Recent Developments
11.9 NAL Pharmaceuticals Ltd.
11.9.1 NAL Pharmaceuticals Ltd. Corporation Information
11.9.2 NAL Pharmaceuticals Ltd. Overview
11.9.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 NAL Pharmaceuticals Ltd. Recent Developments
11.10 ReceptoPharm, Inc.
11.10.1 ReceptoPharm, Inc. Corporation Information
11.10.2 ReceptoPharm, Inc. Overview
11.10.3 ReceptoPharm, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 ReceptoPharm, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 ReceptoPharm, Inc. Recent Developments
11.11 TSRL, Inc.
11.11.1 TSRL, Inc. Corporation Information
11.11.2 TSRL, Inc. Overview
11.11.3 TSRL, Inc. Herpes Zoste Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 TSRL, Inc. Herpes Zoste Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 TSRL, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Herpes Zoste Drug Industry Chain Analysis
12.2 Herpes Zoste Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Herpes Zoste Drug Production Mode & Process
12.4 Herpes Zoste Drug Sales and Marketing
12.4.1 Herpes Zoste Drug Sales Channels
12.4.2 Herpes Zoste Drug Distributors
12.5 Herpes Zoste Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Herpes Zoste Drug Industry Trends
13.2 Herpes Zoste Drug Market Drivers
13.3 Herpes Zoste Drug Market Challenges
13.4 Herpes Zoste Drug Market Restraints
14 Key Findings in The Global Herpes Zoste Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer